 | • レポートコード：MRC2-11QY06751 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は性器ヘルペス治療のグローバル市場について調査・分析したレポートです。種類別（アシクロビル、バラシクロビル、ファムシクロビル）市場規模、用途別（HSV-1、HSV-2）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別性器ヘルペス治療の競争状況、市場シェア ・世界の性器ヘルペス治療市場：種類別市場規模 2015年-2020年（アシクロビル、バラシクロビル、ファムシクロビル） ・世界の性器ヘルペス治療市場：種類別市場規模予測 2021年-2026年（アシクロビル、バラシクロビル、ファムシクロビル） ・世界の性器ヘルペス治療市場：用途別市場規模 2015年-2020年（HSV-1、HSV-2） ・世界の性器ヘルペス治療市場：用途別市場規模予測 2021年-2026年（HSV-1、HSV-2） ・北米の性器ヘルペス治療市場分析：米国、カナダ ・ヨーロッパの性器ヘルペス治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの性器ヘルペス治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の性器ヘルペス治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの性器ヘルペス治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva、Abbott、Sun、Mylan、Pfizer、GlaxoSmithKline、Dr. Reddy's、Novartis、Valeant ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Genital Herpes Treatment Market
The global Genital Herpes Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Genital Herpes Treatment Scope and Market Size
Genital Herpes Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genital Herpes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Genital Herpes Treatment market is segmented into
Acyclovir
Valacyclovir
Famciclovir
Segment by Application, the Genital Herpes Treatment market is segmented into
HSV-1
HSV-2
Regional and Country-level Analysis
The Genital Herpes Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Genital Herpes Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Genital Herpes Treatment Market Share Analysis
Genital Herpes Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Genital Herpes Treatment business, the date to enter into the Genital Herpes Treatment market, Genital Herpes Treatment product introduction, recent developments, etc.
The major vendors covered:
Teva
Abbott
Sun
Mylan
Pfizer
GlaxoSmithKline
Dr. Reddy’s
Novartis
Valeant
1 Study Coverage
1.1 Genital Herpes Treatment Product Introduction
1.2 Market Segments
1.3 Key Genital Herpes Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Genital Herpes Treatment Market Size Growth Rate by Type
1.4.2 Acyclovir
1.4.3 Valacyclovir
1.4.4 Famciclovir
1.5 Market by Application
1.5.1 Global Genital Herpes Treatment Market Size Growth Rate by Application
1.5.2 HSV-1
1.5.3 HSV-2
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Genital Herpes Treatment Market Size, Estimates and Forecasts
2.1.1 Global Genital Herpes Treatment Revenue 2015-2026
2.1.2 Global Genital Herpes Treatment Sales 2015-2026
2.2 Global Genital Herpes Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Genital Herpes Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Genital Herpes Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Genital Herpes Treatment Competitor Landscape by Players
3.1 Genital Herpes Treatment Sales by Manufacturers
3.1.1 Genital Herpes Treatment Sales by Manufacturers (2015-2020)
3.1.2 Genital Herpes Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Genital Herpes Treatment Revenue by Manufacturers
3.2.1 Genital Herpes Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Genital Herpes Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Genital Herpes Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Revenue in 2019
3.2.5 Global Genital Herpes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Genital Herpes Treatment Price by Manufacturers
3.4 Genital Herpes Treatment Manufacturing Base Distribution, Product Types
3.4.1 Genital Herpes Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Genital Herpes Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Genital Herpes Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Genital Herpes Treatment Market Size by Type (2015-2020)
4.1.1 Global Genital Herpes Treatment Sales by Type (2015-2020)
4.1.2 Global Genital Herpes Treatment Revenue by Type (2015-2020)
4.1.3 Genital Herpes Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Genital Herpes Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Genital Herpes Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Genital Herpes Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Genital Herpes Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Genital Herpes Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Genital Herpes Treatment Market Size by Application (2015-2020)
5.1.1 Global Genital Herpes Treatment Sales by Application (2015-2020)
5.1.2 Global Genital Herpes Treatment Revenue by Application (2015-2020)
5.1.3 Genital Herpes Treatment Price by Application (2015-2020)
5.2 Genital Herpes Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Genital Herpes Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Genital Herpes Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Genital Herpes Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Genital Herpes Treatment by Country
6.1.1 North America Genital Herpes Treatment Sales by Country
6.1.2 North America Genital Herpes Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Genital Herpes Treatment Market Facts & Figures by Type
6.3 North America Genital Herpes Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Genital Herpes Treatment by Country
7.1.1 Europe Genital Herpes Treatment Sales by Country
7.1.2 Europe Genital Herpes Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Genital Herpes Treatment Market Facts & Figures by Type
7.3 Europe Genital Herpes Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Genital Herpes Treatment by Region
8.1.1 Asia Pacific Genital Herpes Treatment Sales by Region
8.1.2 Asia Pacific Genital Herpes Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Genital Herpes Treatment Market Facts & Figures by Type
8.3 Asia Pacific Genital Herpes Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Genital Herpes Treatment by Country
9.1.1 Latin America Genital Herpes Treatment Sales by Country
9.1.2 Latin America Genital Herpes Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Genital Herpes Treatment Market Facts & Figures by Type
9.3 Central & South America Genital Herpes Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Genital Herpes Treatment by Country
10.1.1 Middle East and Africa Genital Herpes Treatment Sales by Country
10.1.2 Middle East and Africa Genital Herpes Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Genital Herpes Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Genital Herpes Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description and Business Overview
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Genital Herpes Treatment Products Offered
11.1.5 Teva Related Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Description and Business Overview
11.2.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Genital Herpes Treatment Products Offered
11.2.5 Abbott Related Developments
11.3 Sun
11.3.1 Sun Corporation Information
11.3.2 Sun Description and Business Overview
11.3.3 Sun Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sun Genital Herpes Treatment Products Offered
11.3.5 Sun Related Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Description and Business Overview
11.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Genital Herpes Treatment Products Offered
11.4.5 Mylan Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Genital Herpes Treatment Products Offered
11.5.5 Pfizer Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Genital Herpes Treatment Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Dr. Reddy’s
11.7.1 Dr. Reddy’s Corporation Information
11.7.2 Dr. Reddy’s Description and Business Overview
11.7.3 Dr. Reddy’s Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dr. Reddy’s Genital Herpes Treatment Products Offered
11.7.5 Dr. Reddy’s Related Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Description and Business Overview
11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Genital Herpes Treatment Products Offered
11.8.5 Novartis Related Developments
11.9 Valeant
11.9.1 Valeant Corporation Information
11.9.2 Valeant Description and Business Overview
11.9.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Valeant Genital Herpes Treatment Products Offered
11.9.5 Valeant Related Developments
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description and Business Overview
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Genital Herpes Treatment Products Offered
11.1.5 Teva Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Genital Herpes Treatment Market Estimates and Projections by Region
12.1.1 Global Genital Herpes Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Genital Herpes Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Genital Herpes Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Genital Herpes Treatment Sales Forecast (2021-2026)
12.2.2 North America: Genital Herpes Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Genital Herpes Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Genital Herpes Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Genital Herpes Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Genital Herpes Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Genital Herpes Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Genital Herpes Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Genital Herpes Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Genital Herpes Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Genital Herpes Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Genital Herpes Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Genital Herpes Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Genital Herpes Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Genital Herpes Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Genital Herpes Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Genital Herpes Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Genital Herpes Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Genital Herpes Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Genital Herpes Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Genital Herpes Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Genital Herpes Treatment Market Segments
Table 2. Ranking of Global Top Genital Herpes Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Genital Herpes Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Acyclovir
Table 5. Major Manufacturers of Valacyclovir
Table 6. Major Manufacturers of Famciclovir
Table 7. Global Genital Herpes Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Genital Herpes Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Genital Herpes Treatment Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Genital Herpes Treatment Sales Market Share by Regions (2015-2020)
Table 11. Global Genital Herpes Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Genital Herpes Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Genital Herpes Treatment Sales Share by Manufacturers (2015-2020)
Table 14. Global Genital Herpes Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Genital Herpes Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genital Herpes Treatment as of 2019)
Table 16. Genital Herpes Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Genital Herpes Treatment Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Genital Herpes Treatment Price (2015-2020) (USD/Pcs)
Table 19. Genital Herpes Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Genital Herpes Treatment Product Type
Table 21. Date of International Manufacturers Enter into Genital Herpes Treatment Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Genital Herpes Treatment Sales by Type (2015-2020) (K Pcs)
Table 24. Global Genital Herpes Treatment Sales Share by Type (2015-2020)
Table 25. Global Genital Herpes Treatment Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Genital Herpes Treatment Revenue Share by Type (2015-2020)
Table 27. Genital Herpes Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Genital Herpes Treatment Sales by Application (2015-2020) (K Pcs)
Table 29. Global Genital Herpes Treatment Sales Share by Application (2015-2020)
Table 30. North America Genital Herpes Treatment Sales by Country (2015-2020) (K Pcs)
Table 31. North America Genital Herpes Treatment Sales Market Share by Country (2015-2020)
Table 32. North America Genital Herpes Treatment Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Genital Herpes Treatment Revenue Market Share by Country (2015-2020)
Table 34. North America Genital Herpes Treatment Sales by Type (2015-2020) (K Pcs)
Table 35. North America Genital Herpes Treatment Sales Market Share by Type (2015-2020)
Table 36. North America Genital Herpes Treatment Sales by Application (2015-2020) (K Pcs)
Table 37. North America Genital Herpes Treatment Sales Market Share by Application (2015-2020)
Table 38. Europe Genital Herpes Treatment Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Genital Herpes Treatment Sales Market Share by Country (2015-2020)
Table 40. Europe Genital Herpes Treatment Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Genital Herpes Treatment Revenue Market Share by Country (2015-2020)
Table 42. Europe Genital Herpes Treatment Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Genital Herpes Treatment Sales Market Share by Type (2015-2020)
Table 44. Europe Genital Herpes Treatment Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Genital Herpes Treatment Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Genital Herpes Treatment Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Genital Herpes Treatment Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Genital Herpes Treatment Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Genital Herpes Treatment Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Genital Herpes Treatment Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Genital Herpes Treatment Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Genital Herpes Treatment Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Genital Herpes Treatment Sales Market Share by Application (2015-2020)
Table 54. Latin America Genital Herpes Treatment Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Genital Herpes Treatment Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Genital Herpes Treatment Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Genital Herpes Treatment Revenue Market Share by Country (2015-2020)
Table 58. Latin America Genital Herpes Treatment Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Genital Herpes Treatment Sales Market Share by Type (2015-2020)
Table 60. Latin America Genital Herpes Treatment Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Genital Herpes Treatment Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Genital Herpes Treatment Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Genital Herpes Treatment Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Genital Herpes Treatment Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Genital Herpes Treatment Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Genital Herpes Treatment Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Genital Herpes Treatment Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Genital Herpes Treatment Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Genital Herpes Treatment Sales Market Share by Application (2015-2020)
Table 70. Teva Corporation Information
Table 71. Teva Description and Major Businesses
Table 72. Teva Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Teva Product
Table 74. Teva Recent Development
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Major Businesses
Table 77. Abbott Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Abbott Product
Table 79. Abbott Recent Development
Table 80. Sun Corporation Information
Table 81. Sun Description and Major Businesses
Table 82. Sun Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Sun Product
Table 84. Sun Recent Development
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Major Businesses
Table 87. Mylan Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Mylan Product
Table 89. Mylan Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Major Businesses
Table 92. Pfizer Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Pfizer Product
Table 94. Pfizer Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Major Businesses
Table 97. GlaxoSmithKline Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Dr. Reddy's Corporation Information
Table 101. Dr. Reddy's Description and Major Businesses
Table 102. Dr. Reddy's Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Dr. Reddy's Product
Table 104. Dr. Reddy's Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Major Businesses
Table 107. Novartis Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Novartis Product
Table 109. Novartis Recent Development
Table 110. Valeant Corporation Information
Table 111. Valeant Description and Major Businesses
Table 112. Valeant Genital Herpes Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Valeant Product
Table 114. Valeant Recent Development
Table 115. Global Genital Herpes Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 116. Global Genital Herpes Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Genital Herpes Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Genital Herpes Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Genital Herpes Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. North America: Genital Herpes Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Genital Herpes Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. Europe: Genital Herpes Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Genital Herpes Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 124. Asia Pacific: Genital Herpes Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Genital Herpes Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 126. Latin America: Genital Herpes Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Genital Herpes Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Middle East and Africa: Genital Herpes Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Genital Herpes Treatment Players
Table 133. Genital Herpes Treatment Customers List
Table 134. Genital Herpes Treatment Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Genital Herpes Treatment Product Picture
Figure 2. Global Genital Herpes Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Acyclovir Product Picture
Figure 4. Valacyclovir Product Picture
Figure 5. Famciclovir Product Picture
Figure 6. Global Genital Herpes Treatment Sales Market Share by Application in 2020 & 2026
Figure 7. HSV-1
Figure 8. HSV-2
Figure 9. Genital Herpes Treatment Report Years Considered
Figure 10. Global Genital Herpes Treatment Market Size 2015-2026 (US$ Million)
Figure 11. Global Genital Herpes Treatment Sales 2015-2026 (K Pcs)
Figure 12. Global Genital Herpes Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Genital Herpes Treatment Sales Market Share by Region (2015-2020)
Figure 14. Global Genital Herpes Treatment Sales Market Share by Region in 2019
Figure 15. Global Genital Herpes Treatment Revenue Market Share by Region (2015-2020)
Figure 16. Global Genital Herpes Treatment Revenue Market Share by Region in 2019
Figure 17. Global Genital Herpes Treatment Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Revenue in 2019
Figure 19. Genital Herpes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Genital Herpes Treatment Sales Market Share by Type (2015-2020)
Figure 21. Global Genital Herpes Treatment Sales Market Share by Type in 2019
Figure 22. Global Genital Herpes Treatment Revenue Market Share by Type (2015-2020)
Figure 23. Global Genital Herpes Treatment Revenue Market Share by Type in 2019
Figure 24. Global Genital Herpes Treatment Market Share by Price Range (2015-2020)
Figure 25. Global Genital Herpes Treatment Sales Market Share by Application (2015-2020)
Figure 26. Global Genital Herpes Treatment Sales Market Share by Application in 2019
Figure 27. Global Genital Herpes Treatment Revenue Market Share by Application (2015-2020)
Figure 28. Global Genital Herpes Treatment Revenue Market Share by Application in 2019
Figure 29. North America Genital Herpes Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Genital Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Genital Herpes Treatment Sales Market Share by Country in 2019
Figure 32. North America Genital Herpes Treatment Revenue Market Share by Country in 2019
Figure 33. U.S. Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Genital Herpes Treatment Market Share by Type in 2019
Figure 38. North America Genital Herpes Treatment Market Share by Application in 2019
Figure 39. Europe Genital Herpes Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Genital Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Genital Herpes Treatment Sales Market Share by Country in 2019
Figure 42. Europe Genital Herpes Treatment Revenue Market Share by Country in 2019
Figure 43. Germany Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Genital Herpes Treatment Market Share by Type in 2019
Figure 54. Europe Genital Herpes Treatment Market Share by Application in 2019
Figure 55. Asia Pacific Genital Herpes Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Genital Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Genital Herpes Treatment Sales Market Share by Region in 2019
Figure 58. Asia Pacific Genital Herpes Treatment Revenue Market Share by Region in 2019
Figure 59. China Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Genital Herpes Treatment Market Share by Type in 2019
Figure 82. Asia Pacific Genital Herpes Treatment Market Share by Application in 2019
Figure 83. Latin America Genital Herpes Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Genital Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Genital Herpes Treatment Sales Market Share by Country in 2019
Figure 86. Latin America Genital Herpes Treatment Revenue Market Share by Country in 2019
Figure 87. Mexico Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Genital Herpes Treatment Market Share by Type in 2019
Figure 94. Latin America Genital Herpes Treatment Market Share by Application in 2019
Figure 95. Middle East and Africa Genital Herpes Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Genital Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Genital Herpes Treatment Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Genital Herpes Treatment Revenue Market Share by Country in 2019
Figure 99. Turkey Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Genital Herpes Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Genital Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Genital Herpes Treatment Market Share by Type in 2019
Figure 106. Middle East and Africa Genital Herpes Treatment Market Share by Application in 2019
Figure 107. North America Genital Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 108. North America Genital Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Genital Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. Europe Genital Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Genital Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Asia Pacific Genital Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Genital Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Latin America Genital Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Genital Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Middle East and Africa Genital Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
口唇ヘルペス治療の世界市場（～2026年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Herpes Labialis Treatment Scope and Market Size Herpes Labialis…- 帯状疱疹感染症治療の世界市場（～2026年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…
- 口唇ヘルペス治療・予防の世界市場（～2026年） Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Treatment and Prevention of…
- ヘルペス治療の世界市場（～2026年） Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially. With respect to sexually …
- ヘルペスマーカー検査の世界市場（～2026年） Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial disea…